We are live on ! Find out more
BHC icon

Bausch Health

454 hedge funds and large institutions have $38.7B invested in Bausch Health in 2014 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 163 increasing their positions, 162 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more funds holding in top 10

Funds holding in top 10: 6067 (+7)

1% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $1.37B

1% more capital invested

Capital invested by funds: $38.3B → $38.7B (+$425M)

1% more repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 162

2.25% less ownership

Funds ownership: 90.34%88.09% (-2.2%)

4% less funds holding

Funds holding: 475454 (-21)

28% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 75

Holders
454
Holders Change
-21
Holders Change %
-4.42%
% of All Funds
13.17%
Holding in Top 10
67
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+11.67%
% of All Funds
1.94%
New
54
Increased
163
Reduced
162
Closed
75
Calls
$1.39B
Puts
$1.37B
Net Calls
+$17.9M
Net Calls Change
-$73.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
201
Group One Trading
Illinois
$8.14M +$414K +3,469 +6%
CAM
202
Congress Asset Management
Massachusetts
$7.91M +$388K +3,251 +6%
RP
203
Raiff Partners
New York
$7.87M +$4.77M +40,000 +200%
HAM
204
Highstreet Asset Management
Ontario, Canada
$7.84M +$4.76M +39,933 +201%
YP
205
Yellowstone Partners
Idaho
$7.79M +$42.1K +353 +0.6%
SCM
206
Suffolk Capital Management
New York
$7.67M +$1.29M +10,836 +23%
RSCM
207
Rock Springs Capital Management
Maryland
$7.35M +$89.4K +750 +1%
SM
208
Selkirk Management
New Jersey
$7.28M +$987K +8,284 +18%
Citigroup
209
Citigroup
New York
$7.18M -$510K -4,282 -7%
CIC
210
Chilton Investment Company
Connecticut
$7.15M +$5.22M +43,764 +407%
Marshall Wace
211
Marshall Wace
United Kingdom
$6.99M +$6.35M +53,256 New
William Blair & Company
212
William Blair & Company
Illinois
$6.91M -$54.8K -460 -0.9%
BT
213
Beacon Trust
New Jersey
$6.82M
SCI
214
Seneca Capital Investments
New York
$6.73M -$3.42M -28,700 -36%
NFA
215
Nationwide Fund Advisors
Ohio
$6.73M -$71.5K -600 -1%
PL
216
Parkwood LLC
Ohio
$6.7M -$137K -1,146 -2%
CI Investments Inc
217
CI Investments Inc
Ontario, Canada
$6.56M +$5.96M +50,000 New
VRS
218
Virginia Retirement Systems
Virginia
$6.51M +$977K +8,200 +20%
Dimensional Fund Advisors
219
Dimensional Fund Advisors
Texas
$6.19M +$216K +1,815 +4%
Lord, Abbett & Co
220
Lord, Abbett & Co
New Jersey
$5.86M +$5.32M +44,632 New
PAMP
221
Polar Asset Management Partners
Ontario, Canada
$5.77M +$179K +1,500 +4%
AIM
222
Allen Investment Management
New York
$5.76M +$233K +1,954 +5%
Nomura Holdings
223
Nomura Holdings
Japan
$5.72M -$397K -3,330 -7%
AllianceBernstein
224
AllianceBernstein
Tennessee
$5.71M -$12.7M -106,489 -71%
HS
225
HighVista Strategies
Massachusetts
$5.61M +$506K +4,245 +11%

BHC Hedge Fund Activity: Q3 2014 in Review

454 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2014, worth a combined $38.7B — up 1.1% from $38.3B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of BHC and 54 opened new positions — a net loss of 21 holders — while 162 trimmed existing stakes and 163 added.

The largest buyer was Fir Tree Capital Management, opening a new position worth an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $402M.

  • 454 institutional investors held Bausch Health (BHC) as of Q3 2014, down from 475 in Q2 2014.
  • Funds reported $38.7B of Bausch Health stock for Q3 2014, up 1.1% quarter-over-quarter.
  • 54 funds opened new Bausch Health positions in Q3 2014 and 75 closed out, a net change of -21 holders.
  • The largest Bausch Health buyer in Q3 2014 was Fir Tree Capital Management, an estimated $158M added.
  • The largest Bausch Health seller in Q3 2014 was Fidelity Investments, an estimated $402M sold.

Based on aggregated 13F filings for Q3 2014.